Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
Stock Snapshot
With a market cap of 87.27B, Regeneron(REGN) trades at $767.61. The stock has a price-to-earnings ratio of 18.85 and currently yields dividends of 0.48%.
As of 2026-08-03, Regeneron(REGN) stock has fluctuated between $723.01 and $764.65. The current price stands at $767.61, placing the stock +6.2% above today's low and +0.4% off the high.
Regeneron(REGN) shares are trading with a volume of 1.16M, against a daily average of 905.79K.
During the past year, Regeneron(REGN) stock moved between $541.00 at its lowest and $821.11 at its peak.
During the past year, Regeneron(REGN) stock moved between $541.00 at its lowest and $821.11 at its peak.
REGN News
...
Regeneron Pharmaceuticals (REGN), Sanofi SA (SNY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to...
RBC Capital raised the firm’s price target on Regeneron (REGN) to $737 from $696 and keeps a Sector Perform rating on the shares. The company reported strong sa...
Analyst ratings
68%
of 31 ratingsMore REGN News
AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...
Regeneron Pharmaceuticals ((REGN)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing...
Dupixent Drives Growth While Vaccines Sales Decline Dupixent sales increased by 37.6% to 5.154 billion euros, above 5 billion euros per quarter for the first t...
Yves Herman / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....
Regeneron Pharmaceuticals (REGN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, mo...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is facing a federal securities lawsuit alleging that investors were not fully informed about risks tied to a Phas...
Kiniksa Pharmaceuticals (KNSA) added nearly 50% on Tuesday after posting another quarterly beat and guidance boost with its financials, thanks mainly to Arcalys...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.